Anavex Life Sciences Corp (AVXL)

[JWC3]

So say we get 50% of the 400000 possible candidate patients approved for compassionate use of A 2-73. Additionally suppose ANAVEX charges a reasonable $3000 / year. So yearly revenue would be:

200000x3000 = $600,000,000. Per year!!!!!


At 5times revenue the market cap would be $3B and the stock price would be approximately $55.